108 related articles for article (PubMed ID: 23134824)
1. Comparison of computed tomography versus magnetic resonance imaging in assessing radiofrequency ablation margins after radiofrequency ablation in patients with hepatocellular carcinomas.
Qu JR; Liu CC; Zhang HK; Li X; Zhang JW; Luo JP; Shao NN; Zhang SN; Li YL; Li HL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):480-5. PubMed ID: 23134824
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas.
Yoon JH; Lee EJ; Cha SS; Han SS; Choi SJ; Juhn JR; Kim MH; Lee YJ; Park SJ
J Vasc Interv Radiol; 2010 Mar; 21(3):348-56. PubMed ID: 20116285
[TBL] [Abstract][Full Text] [Related]
3. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of contrast-enhanced US versus CT or MRI for the therapeutic control of percutaneous radiofrequency ablation in the case of hepatic malignancies.
Frieser M; Kiesel J; Lindner A; Bernatik T; Haensler JM; Janka R; Hahn EG; Strobel D
Ultraschall Med; 2011 Apr; 32(2):148-53. PubMed ID: 21225567
[TBL] [Abstract][Full Text] [Related]
5. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of hepatocellular carcinoma: predicting success using contrast-enhanced sonography.
Dill-Macky MJ; Asch M; Burns P; Wilson S
AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S287-95. PubMed ID: 16632690
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
Wu J; Chen MH; Yang W; Wu W; Yan K
Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
[TBL] [Abstract][Full Text] [Related]
8. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
9. Local tumour progression after loco-regional therapy of hepatocellular carcinomas: value of fusion imaging-guided radiofrequency ablation.
Min JH; Lee MW; Rhim H; Cha DI; Lim S; Choi SY; Lim HK
Clin Radiol; 2014 Mar; 69(3):286-93. PubMed ID: 24332169
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional registration of images obtained before and after radiofrequency ablation of hepatocellular carcinoma to assess treatment adequacy.
Sakakibara M; Ohkawa K; Katayama K; Imanaka K; Ishihara A; Hasegawa N; Kimura H
AJR Am J Roentgenol; 2014 May; 202(5):W487-95. PubMed ID: 24758684
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
[TBL] [Abstract][Full Text] [Related]
12. Is there a need for MRI within 24 hours after CT-guided percutaneous thermoablation of the liver?
Ringe KI; Wacker F; Raatschen HJ
Acta Radiol; 2015 Jan; 56(1):10-7. PubMed ID: 24445091
[TBL] [Abstract][Full Text] [Related]
13. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.
Kim SH; Kim SH; Lee J; Kim MJ; Jeon YH; Park Y; Choi D; Lee WJ; Lim HK
AJR Am J Roentgenol; 2009 Jun; 192(6):1675-81. PubMed ID: 19457834
[TBL] [Abstract][Full Text] [Related]
14. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
15. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced ultrasound in the characterization of hepatocellular carcinomas treated by ablation: comparison with contrast-enhanced magnetic resonance imaging.
Qu P; Yu X; Liang P; Cheng Z; Han Z; Liu F; Yu J
Ultrasound Med Biol; 2013 Sep; 39(9):1571-9. PubMed ID: 23830098
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
[TBL] [Abstract][Full Text] [Related]
18. Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy?
Watanabe H; Kanematsu M; Goshima S; Yoshida M; Kawada H; Kondo H; Moriyama N
AJR Am J Roentgenol; 2012 Mar; 198(3):589-95. PubMed ID: 22357997
[TBL] [Abstract][Full Text] [Related]
19. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
Koda M; Tokunaga S; Okamoto T; Hodozuka M; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Sugihara T; Oyama K; Hosho K; Okano J; Murawaki Y; Kakite S; Yamashita E
J Hepatol; 2015 Dec; 63(6):1360-7. PubMed ID: 26232269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
